Monoclonal antibodies and cocktails for treatment of Ebola infections
US11242379B2 · kind B2 · utility
1Cited by
9References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 9, 2020 |
| Grant date | Feb 8, 2022 |
| Priority date | — |
| Expiry date | Jul 21, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.